Considering that BRCA1/2 mutation carriers have a significantly increased risk of prostate cancer and that prostate cancer in BRCA1/2 mutation carriers is known to be more aggressive with a worse prognosis [28,29,30], it is crucial to emphasize the importance of prostate cancer surveillance to male carriers. The gene discussed is BRCA1; the disease is prostate carcinoma.